These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 116154)

  • 21. Effect of supplementation of ergosterol on miconazole action in vivo and in vitro in Candida albicans.
    Mago N; Khuller GK
    Indian J Exp Biol; 1991 Sep; 29(9):841-4. PubMed ID: 1794867
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cytochemical and biochemical studies of yeasts after in vitro exposure to miconazole.
    De Nollin S; Van Belle H; Goossens F; Thone F; Borgers M
    Antimicrob Agents Chemother; 1977 Mar; 11(3):500-13. PubMed ID: 193437
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Further studies on factors controlling phenotypic susceptibility of Candida albicans to miconazole kill.
    Beggs WH
    Res Commun Chem Pathol Pharmacol; 1990 Jan; 67(1):159-62. PubMed ID: 2183320
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis and antimycotic activity of alpha-aryl-beta,N-imidazolylalkyl benzyl ethers.
    Tajana A; Cappelletti R; Leonardi A; Nardi D; Veronese M
    Arzneimittelforschung; 1981; 31(12):2121-3. PubMed ID: 6800383
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Influence of alkaline pH on the direct lethal action of miconazole against Candida albicans.
    Beggs WH
    Mycopathologia; 1992 Oct; 120(1):11-3. PubMed ID: 1480204
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antagonism of the direct fungicidal action of miconazole by miconazole fungistasis.
    Beggs WH; LaSota IR; Hughes CE
    Eur J Clin Microbiol Infect Dis; 1988 Jun; 7(3):413-4. PubMed ID: 3137047
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Resistance of Candida albicans to direct lethal miconazole action induced by low-level miconazole.
    Beggs WH
    Mycoses; 1991; 34(5-6):227-30. PubMed ID: 1795717
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of miconazole on ergosterol-less mutant of Candida albicans.
    Pesti M; Becher D; Bartsch G
    Acta Microbiol Hung; 1983; 30(1):25-9. PubMed ID: 6362313
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of ergosterol synthesis by sertaconazole in Candida albicans.
    Agut J; Palacín C; Sacristán A; Ortiz JA
    Arzneimittelforschung; 1992 May; 42(5A):718-20. PubMed ID: 1627190
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Comparative action of 8 azole derivatives against Candida albicans: fungistatic action and cytologic study by scanning electron microscopy].
    Mallie M; Jouvert S; Bastide M; Montes B; Lebecq JC; Bastide JM
    Pathol Biol (Paris); 1988 May; 36(5):575-80. PubMed ID: 3043361
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro antifungal activity of sertaconazole.
    Drouhet E; Dupont B
    Arzneimittelforschung; 1992 May; 42(5A):705-10. PubMed ID: 1627187
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Changes in the activity of antifungals in mixed cultures of bacteria and yeasts.
    Domon MH; Mathieu LG; de Repentigny J
    Can J Microbiol; 1981 Aug; 27(8):843-6. PubMed ID: 6794898
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tensidols, new potentiators of antifungal miconazole activity, produced by Aspergillus niger FKI-2342.
    Fukuda T; Hasegawa Y; Hagimori K; Yamaguchi Y; Masuma R; Tomoda H; Omura S
    J Antibiot (Tokyo); 2006 Aug; 59(8):480-5. PubMed ID: 17080684
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effects of miconazole on the ultrastructure of Candida albicans.
    de Nollin S; Borgers M
    Proc R Soc Med; 1977; 70 Suppl 1(Suppl 1):9-12. PubMed ID: 233843
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Changes in the cellular composition of Candida albicans resistant to miconazole.
    Sharma S; Khuller GK
    Indian J Biochem Biophys; 1996 Oct; 33(5):420-4. PubMed ID: 9029825
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development of phenotypic resistance to direct lethal miconazole action by Candida albicans entering stationary phase.
    Beggs WH
    Mycopathologia; 1989 Dec; 108(3):201-6. PubMed ID: 2693969
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Synergistic effect of clotrimazole and hexamidinediisethionate against Candida albicans].
    Früh H
    Mykosen; 1985 Oct; 28(10):495-500. PubMed ID: 3906390
    [No Abstract]   [Full Text] [Related]  

  • 38. Azole resistance in Candida albicans.
    Smith KJ; Warnock DW; Kennedy CT; Johnson EM; Hopwood V; Van Cutsem J; Vanden Bossche H
    J Med Vet Mycol; 1986 Apr; 24(2):133-44. PubMed ID: 3014106
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Candida albicans isolates from APECED patients show decreased susceptibility to miconazole.
    Siikala E; Richardson M; Pfaller MA; Diekema DJ; Messer SA; Perheentupa J; Saxén H; Rautemaa R
    Int J Antimicrob Agents; 2009 Dec; 34(6):607-9. PubMed ID: 19748230
    [No Abstract]   [Full Text] [Related]  

  • 40. Antimicrobial activity of a new derivative: N-(4-chlorobenzyl)-2-(1H-imidazol-1-ylmethyl)benzenamine.
    Panico S; Villa A; Simonetti N; Porretta GC; Scalzo M
    Drugs Exp Clin Res; 1990; 16(4):181-6. PubMed ID: 2076654
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.